Identification of Peptide Ligands for Targeting to the Blood-Brain Barrier

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands.
Pharmaceutical Research (Impact Factor: 3.42). 02/2010; 27(4):673-82. DOI: 10.1007/s11095-010-0053-6
Source: PubMed


Transport of drugs to the brain is limited by the blood-brain barrier. New, specific brain endothelium ligands can facilitate brain-specific delivery of drugs.
We used phage display in an in situ brain perfusion model to screen for new brain endothelium peptide ligands.
Two phage clones, displaying 15 amino acid-peptides (GLA and GYR) that were selected for brain binding in the mouse model, showed significant binding to human brain endothelium (hCMEC/D3), compared to a random control phage. This binding was not seen for other human endothelial cells (HUVEC). Binding to hCMEC/D3 cells was dose dependent. When phage GLA and GYR were individually perfused through the murine brain, their ability to bind to the brain was 6-fold (GLA) and 5-fold (GYR) higher than the control phage. When compared to lung perfusion, phage showed an 8.5-fold (GYR) and 48-fold (GLA) preference for brain over lung compared to the control.
These results indicate that two new peptide ligands have been identified that may be used for specific targeting of drugs to the blood-brain barrier.

Download full-text


Available from: Raymond Schiffelers
  • Source
    • "The honokiol was also administered to other male Sprague-Dawley rats ((8∼10 weeks old, 220∼260 g, n = 24) at a single dose of 20 mg/kg body weight via caudal vein. The time for respective 5 min, 30 min, 60 min and 120 min (Six rats per time point) post administration was designated to collect the cerebrospinal fluid (CSF), brain and other tissues after cardiac perfusion through left ventricle using the perfusion method described previously [38] to determinate exactly the amount of honokiol. Rats were perfused with Krebs-Henseleit buffer (118 mM NaCl, 14.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 25 mM NaHCO3, 10 mM D-glucose, pH 7.4) containing heparin (5 U/mL). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gliosarcoma is one of the most common malignant brain tumors, and anti-angiogenesis is a promising approach for the treatment of gliosarcoma. However, chemotherapy is obstructed by the physical obstacle formed by the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB). Honokiol has been known to possess potent activities in the central nervous system diseases, and anti-angiogenic and anti-tumor properties. Here, we hypothesized that honokiol could cross the BBB and BCSFB for the treatment of gliosarcoma.
    Preview · Article · Apr 2011 · PLoS ONE
  • Source
    • "In many cases these sequences were similar to those of known ligands for endothelial cell-surface proteins. This methodology is now being used in a number of ways to target therapeutic and diagnostic agents to the vasculature of solid tumors as well as other pathological blood vessels or even cancer cells[[4], through phage display technology two new peptide ligands were identified showing significant binding to both mouse brain vasculature and human brain capillary endothelial cell line hCMEC/D3. This approach may prove important for key target validation in preclinical animal models of CNS diseases and disorders in relation to human for brain-specific targeting and drug delivery with phage-based peptide delivery systems. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diverse technologies such as phage display, cell systematic evolution of ligands by exponential enrichment and related modifications thereof are generating a wide range of peptide-based and structured nucleic acid (aptamers)-based ligands for therapeutic and diagnostic interventions in an unbiased biological context. Their impressive affinity and unprecedented target specificity make these ligands as ideal small-sized candidates for conjugation to macromolecules and nanoparticulate matters, thus opening the path to new and sophisticated design solutions for targeted therapy, disease detection and diagnosis. Vascular beds of many organs and tissue, cancer, immune and stem cells are among the key targets. These technologies are evaluated and selected recent examples of innovative biological targeting and therapeutic interventions with phage-displayed peptides and aptamers are discussed.
    Full-text · Article · Mar 2011 · Current Opinion in Biotechnology
  • [Show abstract] [Hide abstract]
    ABSTRACT: The authors studied the electric field distribution in flat cables as a function of dimensions and isolation materials. If the maximum electrical stress is higher than 25 kV/in, corona will be generated. The parametric study indicated that the electrical stress can be reduced by the proper selection of conductor dimensions, the use of semiconductive polytetrafluoroethylene (PTFE) material, and rounding off of the edges. The results of the calculations were verified by high-voltage tests in which the corona inception voltage of typical designs was measured. The calculated inception voltage correlated well with the measured voltage
    No preview · Conference Paper · Jul 1992
Show more